Drug · DIN 02511266
ELETRIPTAN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 22, 2021; first marketed July 22, 2021.
- Drug Identification Number (DIN)
- 02511266
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Eletriptan N02CC06
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ELETRIPTAN (ELETRIPTAN HYDROBROMIDE) | 20 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 22, 2021: NOC 25057Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named ELETRIPTAN
- DIN 02511274 · Marketed